Clinical Trials in Illinois

Showing 3281-3300 of 9,411 trials

Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

NCT03942601

This is a prospective, multi-center, pilot feasibility study to document the effects of adventitial delivery of temsirolimus or temsirolimus with dexamethasone sodium phosphate injection, USP, after revascularization of femoropopliteal lesions in symptomatic patients with moderate to severe claudication (Rutherford 2-3) or critical limb ischemia (CLI) with rest pain (Rutherford 4). Subjects will be followed for up to 60 months post index procedure.

Peripheral Arterial Disease

Mercator MedSystems, Inc.10 participantsStarted Oct 2019

Little Rock, Arkansas, United States • Orange, California, United States • San Francisco, California, United States +8 more locations

TERMINATEDPhase 3125 miles

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

NCT02914600

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior filgotinib treatment study in Crohn's disease (CD).

Crohn's Disease

Galapagos NV1,188 participantsStarted Mar 2017

Dothan, Alabama, United States • Sun City, Arizona, United States • Coronado, California, United States +483 more locations

Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Find Trials by Condition in Illinois

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT

A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders

Suicide Treatment Alternatives for Teens

A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop

Teaching Loved Ones to Help Veterans Optimize Their PTSD Care and Healing

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.

TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT